(734) An Analysis of the Safety of Penile Implant Surgery in Octogenarians

Introduction There is a correlation between age and severity of ED and therefore failure to respond to erectogenic pharmacotherapy. In contemporary society with increasing life expectancy, sexual health practitioners are increasingly encountering octogenarians with ED who are seeking to continue sexual activity. IPP is a recognized option for ED especially after failure to respond to ED medications. Objective The aim of this study was to evaluate the safety and outcomes of IPP in men ≥80 years. Methods A retrospective, international, multi-centre analysis was conducted evaluating primary or revision IPP in the octogenarian population. Data analysed included: cause of ED, severity of ED based on IIEF scores, comorbidity profile. ASA score, type of implant, hospital stay, complication profile, timing of inflation/deflation training, time to commencement of IPP use and re-hospitalisation within 30 days of operation. The anaesthesiologist determined ASA score preoperatively, where: I =healthy patient; II = mild systemic disease; III = severe systemic disease; IV = severe systemic disease that is constant threat to life. Results To date, 48 men are included in the analysis. Median age at IPP surgery was 82 years (IQR81, 87). Median number of comorbidities was 3 (IQR 2,4). Pre-IPP, 25% had pelvic radiation therapy, 22% had radical prostatectomy, 11% had androgen deprivation therapy and 28% were diabetic. 92%of patients had ASA of ≤3 (ASA 1 =0, ASA2 =18, ASA 3 =26, ASA 4 =4). 72% were primary penile implant cases. 95% had IPP, the remaining had a malleable implant (n=2) For IPP: Penoscrotal approach was performed in 85%. AMS IPP were inserted in 55% with the remainder had a Coloplast Titan. 77% of patients were discharged on the day of surgery, the remaining on day 1. There were no re-admissions within 30 days and no postoperative cardiorespiratory events were encountered. Infection was reported in 1/48 patients (2.1%). Revision surgery needed in 2/48 (4.2%)- both for pump scarring. Median time to commencement of IPP use by patients was 42 (IQR40, 49) days. Conclusions Penile implants are well tolerated in carefully selected octogenarians undergoing penile prosthesis surgery. Disclosure No